Home Newsfeeds Canaccord Genuity Maintains Sell on Canopy Gwth, Lowers Price Target to C$3.5

Canaccord Genuity Maintains Sell on Canopy Gwth, Lowers Price Target to C$3.5

Canaccord Genuity analyst Matt Bottomley maintains Canopy Gwth (TSX:WEED) with a Sell and lowers the price target from C$4.5 to C$3.5.

byBenzinga Newsdesk

July 1, 2022

1 minute read

Canaccord Genuity analyst Matt Bottomley maintains Canopy Gwth (TSX:WEED) with a Sell and lowers the price target from C$4.5 to C$3.5.

Oppenheimer Upgrades Verizon Communications to Outperform, Announces $50 Price Target

By Benzinga Newsdesk

October 6, 6:14 AM

Oppenheimer analyst Timothy Horan upgrades Verizon Communications (NYSE:VZ) from Perform to Outperform and announces $50 price target.

Wells Fargo Maintains Overweight on Douglas Emmett, Lowers Price Target to $24

By Benzinga Newsdesk

August 30, 7:56 AM

Wells Fargo analyst Blaine Heck maintains Douglas Emmett (NYSE:DEI) with a Overweight and lowers the price target from $28 to $24.

DEI

Evercore ISI Group Upgrades Enanta Pharmaceuticals to Outperform, Announces $62 Price Target

By Benzinga Newsdesk

July 6, 8:24 AM

Evercore ISI Group analyst Liisa Bayko upgrades Enanta Pharmaceuticals (NASDAQ:ENTA) from In-Line to Outperform and announces $62 price target.

ENTA

Insmed Earlier Reported Q2 EPS $(0.80) Beats $(0.89) Estimate, Sales $65.22M Beat $59.41M Estimate

By Bill Haddad

August 4, 9:55 AM

Insmed (NASDAQ:INSM) reported quarterly losses of $(0.80) per share which beat the analyst consensus estimate of $(0.89) by 10.11 percent. This is a 12.09 percent increase over losses of $(0.91) per share from the same

INSM

Canaccord Genuity Maintains Sell on Canopy Gwth, Lowers Price Target to C$3.5

Related Posts

Oppenheimer Upgrades Verizon Communications to Outperform, Announces $50 Price Target

Wells Fargo Maintains Overweight on Douglas Emmett, Lowers Price Target to $24

Evercore ISI Group Upgrades Enanta Pharmaceuticals to Outperform, Announces $62 Price Target

Insmed Earlier Reported Q2 EPS $(0.80) Beats $(0.89) Estimate, Sales $65.22M Beat $59.41M Estimate